Universidad San Jorge   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Zaragoza Spain (2005)

Organization Overview

First Clinical Trial
2006
NCT00609375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital san Jorge, Pereira | Hospital Universitario San Jorge | Hospital Universitario San Jorge de Pereira | Hospital Universitario San Jorge de Pereira (HUSJ) | Hospital Universitario San Jorge (Huesca) | Universidad San Jorge

Active Ingredients

Drugs in Phase 4 Trials (1)

cefepime (maxipeme) (1 trial)

Drugs in Phase 3 Trials (3)

berberine (1 trial)

cholesterol (1 trial)

policosanol (1 trial)

Drugs in Phase 2 Trials (2)

hypochlorous acid (1 trial)

povidone-iodine (betadine) (1 trial)

Drugs in Other Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Communicable Diseases (Phase 2)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hypertriglyceridemia (Phase 3)

Infections (Phase 2)

Surgical Wound Infection (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7